NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
213 hedge funds and large institutions have $3.63B invested in NPS PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 68 increasing their positions, 83 reducing their positions, and 28 closing their positions.
61% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 28
60% more call options, than puts
Call options by funds: $104M | Put options by funds: $64.9M
39% more capital invested
Capital invested by funds: $2.61B → $3.63B (+$1.02B)
7% more funds holding
Funds holding: 200 → 213 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
18% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 83
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$70.9M |
| 2 |
Goldman Sachs
New York
|
+$25.4M |
| 3 |
FCE
Fiera Capital (Europe)
Grand Cayman,
Cayman Islands
|
+$12.6M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$11.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$29.9M |
| 2 |
Millennium Management
New York
|
-$19.3M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$17.9M |
| 4 |
VAM
Visium Asset Management
New York
|
-$17M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$15.2M |
NPSP Hedge Fund Activity: Q4 2014 in Review
213 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2014, worth a combined $3.63B — up 39% from $2.61B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new NPSP positions and 28 closed out — a net gain of 17 holders — while 68 added to existing stakes and 83 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $70.9M. The largest seller was Wells Fargo, cutting an estimated $29.9M.
- 213 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2014, up from 200 in Q3 2014.
- Funds reported $3.63B of NPS PHARMACEUTICALS INC stock for Q4 2014, up 39% quarter-over-quarter.
- 45 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2014 and 28 closed out, a net change of +17 holders.
- The largest NPS PHARMACEUTICALS INC buyer in Q4 2014 was First Trust Advisors, an estimated $70.9M added.
- The largest NPS PHARMACEUTICALS INC seller in Q4 2014 was Wells Fargo, an estimated $29.9M sold.
Based on aggregated 13F filings for Q4 2014.